We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $680M
1-Year Est. Return 47.51%
This Fund
S&P 500
This Quarter Est. Return
+18.61%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$680M
AUM Growth
+$12.5M
Cap. Flow
-$82.1M
Cap. Flow %
-12.07%
Top 10 Hldgs %
19.1%
Holding
216
New
16
Increased
34
Reduced
132
Closed
17

Top Buys

1
AZN icon
AstraZeneca
AZN
+$8.52M
2
NRG icon
NRG Energy
NRG
+$6.36M
3
SNX icon
TD Synnex
SNX
+$5.16M
4
SYK icon
Stryker
SYK
+$3.97M
5
DE icon
Deere & Co
DE
+$3.68M

Sector Composition

1 Financials 16.71%
2 Industrials 16.07%
3 Technology 15.33%
4 Healthcare 10.36%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOT icon
101
Boot Barn
BOOT
$4.63B
$1.99M 0.29%
+12,135
New +$1.97M
NVST icon
102
Envista
NVST
$4.35B
$1.97M 0.29%
74,749
-18,183
-20% -$459K
ANIP icon
103
ANI Pharmaceuticals
ANIP
$1.8B
$1.97M 0.29%
23,738
-7,782
-25% -$624K
AUGO
104
Aura Minerals Inc
AUGO
$4.19B
$1.94M 0.29%
30,893
-16,004
-34% -$1.26M
CWK icon
105
Cushman & Wakefield Ltd
CWK
$3.2B
$1.92M 0.28%
143,483
-86,451
-38% -$1.16M
BANC icon
106
Banc of California
BANC
$3.27B
$1.89M 0.28%
92,753
-61,080
-40% -$1.16M
IDA icon
107
Idacorp
IDA
$8.24B
$1.88M 0.28%
12,416
-10,491
-46% -$1.51M
HWC icon
108
Hancock Whitney
HWC
$6.37B
$1.86M 0.27%
24,901
-15,142
-38% -$1.04M
ACIW icon
109
ACI Worldwide
ACIW
$5.9B
$1.83M 0.27%
36,487
-318
-0.9% -$13.8K
WTFC icon
110
Wintrust Financial
WTFC
$11.1B
$1.83M 0.27%
11,375
-9,950
-47% -$1.5M
TNL icon
111
Travel + Leisure Co
TNL
$4.57B
$1.82M 0.27%
23,761
-20,878
-47% -$1.47M
AAOI icon
112
Applied Optoelectronics
AAOI
$8.22B
$1.81M 0.27%
12,250
-5,678
-32% -$923K
URBN icon
113
Urban Outfitters
URBN
$6.25B
$1.8M 0.26%
25,354
-18,444
-42% -$1.31M
PIPR icon
114
Piper Sandler
PIPR
$5.16B
$1.78M 0.26%
24,597
-18,480
-43% -$1.5M
SM icon
115
SM Energy
SM
$7.51B
$1.78M 0.26%
68,050
-30,116
-31% -$905K
GTES icon
116
Gates Industrial
GTES
$6.76B
$1.77M 0.26%
63,335
-41,825
-40% -$1.07M
WSFS icon
117
WSFS Financial
WSFS
$4.16B
$1.76M 0.26%
22,921
-11,507
-33% -$825K
JPM icon
118
JPMorgan Chase
JPM
$907B
$1.73M 0.25%
5,272
-2
-0% -$621
GATX icon
119
GATX Corp
GATX
$6.34B
$1.72M 0.25%
9,684
-5,654
-37% -$1.03M
ARCB icon
120
ArcBest
ARCB
$3.56B
$1.63M 0.24%
11,324
-9,396
-45% -$1.22M
BRK.B icon
121
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.61M 0.24%
3,225
-90
-3% -$43.3K
TCBI icon
122
Texas Capital Bancshares
TCBI
$4.59B
$1.59M 0.23%
15,355
-13,446
-47% -$1.35M
CPRX icon
123
Catalyst Pharmaceutical
CPRX
$1.56M 0.23%
49,744
-46,892
-49% -$1.38M
MGY icon
124
Magnolia Oil & Gas
MGY
$5.04B
$1.55M 0.23%
60,651
-37,763
-38% -$1.08M
OSIS icon
125
OSI Systems
OSIS
$3.51B
$1.55M 0.23%
7,088
-9,095
-56% -$2.23M

Similar funds

Oliver Luxxe Assets's Q2 2026 Portfolio in Review

As of Q2 2026, Oliver Luxxe Assets held 216 positions worth $680M, up 1.9% from $668M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oliver Luxxe Assets withdrew a net $82.1M in Q2 2026, closing 17 positions and reducing 132 holdings. Its most notable exit was HCA Healthcare, an estimated $6.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Oliver Luxxe Assets opened a new position in AstraZeneca worth $8.52M.

  • Oliver Luxxe Assets's largest Q2 2026 buy was AstraZeneca: 45,272 shares worth $8.52M.
  • Oliver Luxxe Assets added most to TE Connectivity in Q2 2026, an estimated $2.72M increase.
  • Oliver Luxxe Assets's biggest Q2 2026 reduction was Sanmina, cutting an estimated $3.63M.
  • Oliver Luxxe Assets fully exited HCA Healthcare in Q2 2026, selling an estimated $6.62M.
  • Oliver Luxxe Assets's ten largest holdings make up 19% of its $680M portfolio in Q2 2026.
  • Oliver Luxxe Assets opened 16 new positions and closed 17 in Q2 2026.
  • Oliver Luxxe Assets's portfolio value rose 1.9% quarter-over-quarter to $680M.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.